PFENYSESEC EDGAREDGAR

PFIZER INC

Pharmaceutical Preparations·NEW YORK, NY·FY end 12/31·CIK 78003

Board of Directors

12 members · 11 independent · FY 2025
DirectorRoleTenureAgeCommitteesIndep.Annual fees
Ronald E. BlaylockDirector9y66AuditComp—
Albert BourlaChairman and CEO8y64———
Mortimer J. BuckleyDirector2y56AuditGovernance—
Susan Desmond-HellmannDirector6y68GovernanceTech—
Joseph J. EchevarriaDirector11y69AuditGovernance—
Scott GottliebDirector7y53Regulatory and ComplianceTech—
Dan R. LittmanDirector8y73GovernanceRegulatory and ComplianceTech—
Shantanu NarayenLead Independent Director13y62——
Suzanne Nora JohnsonDirector19y68AuditRegulatory and Compliance—
James QuinceyDirector6y61Comp—
James C. SmithDirector12y66AuditComp—
Cyrus TaraporevalaDirector2y59AuditComp—

Risk-factor diff

10-K Item 1A — YoY changes

Need at least two years of 10-K filings to compute. Will populate once both this year's and last year's 10-Ks have been ingested.

Policies & disclosures

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.